FNAM — Evolutionary Genomics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $0.00m
- $9.03m
Annual cashflow statement for Evolutionary Genomics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.1 | -0.793 | -1.71 | -2.79 | -1.93 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.361 | 0.042 | 0.04 | 0.136 | 0.115 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.052 | 0.052 | -0.047 | 0.036 | 0.157 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.749 | -0.626 | -2.3 | -1.58 | -0.641 |
| Other Investing Cash Flow Items | 0 | 0 | 0.148 | 0 | 0 |
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | 0.148 | 0 | 0 |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | 0.54 | 2.32 | 1.58 | 1 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.749 | -0.086 | 0.17 | -0.002 | 0.363 |